PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.21%
Revenue growth above 1.5x 3391.T's 2.67%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
8.31%
Gross profit growth above 1.5x 3391.T's 0.84%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
25.60%
Positive EBIT growth while 3391.T is negative. John Neff might see a substantial edge in operational management.
27.07%
Positive operating income growth while 3391.T is negative. John Neff might view this as a competitive edge in operations.
40.70%
Positive net income growth while 3391.T is negative. John Neff might see a big relative performance advantage.
40.71%
Positive EPS growth while 3391.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
40.71%
Positive diluted EPS growth while 3391.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
51.58%
10Y revenue/share CAGR under 50% of 3391.T's 183.99%. Michael Burry would suspect a lasting competitive disadvantage.
-16.43%
Negative 5Y CAGR while 3391.T stands at 117.81%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
39.52%
3Y revenue/share CAGR at 50-75% of 3391.T's 64.38%. Martin Whitman would question if the firm lags behind competitor innovations.
-100.00%
Negative 10Y OCF/share CAGR while 3391.T stands at 100.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
146.54%
Below 50% of 3391.T's 346.40%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
26.35%
Below 50% of 3391.T's 66.33%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
62.87%
3Y net income/share CAGR similar to 3391.T's 60.33%. Walter Schloss would attribute it to shared growth factors or demand patterns.
172.32%
10Y equity/share CAGR in line with 3391.T's 180.29%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
21.13%
Below 50% of 3391.T's 81.96%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
67.38%
3Y equity/share CAGR above 1.5x 3391.T's 43.13%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-25.00%
Cut dividends over 10 years while 3391.T stands at 81174.79%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
50.00%
5Y dividend/share CAGR at 50-75% of 3391.T's 90.00%. Martin Whitman might see a lagging policy in mid-term shareholder returns.
38.46%
3Y dividend/share CAGR at 75-90% of 3391.T's 44.08%. Bill Ackman wants overhead or revenue enhancements to match competitor's dividend growth.
23035.00%
AR growth well above 3391.T's 4.15%. Michael Burry fears inflated revenue or higher default risk in the near future.
10.52%
We show growth while 3391.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
6.02%
Asset growth 1.25-1.5x 3391.T's 5.45%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
5.55%
Similar to 3391.T's 5.34%. Walter Schloss finds parallel capital usage or profit distribution strategies.
1.97%
We have some new debt while 3391.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-46.41%
We cut SG&A while 3391.T invests at 6.50%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.